Despite significant progress in biomarker testing for detection of actionable mutations, many patients with advanced and metastatic non-small cell lung cancer (NSCLC) still do not receive comprehensive guideline-concordant testing.Join two nationally recognized experts in NSCLC as they explore real-world challenges and evidence-based strategies to improve comprehensive biomarker testing and treatment decision-making for patients with NSCLC.Drawing on insights from a national quality improvement initiative, faculty explore common barriers and facilitators to timely, comprehensive testing, including tissue and ctDNA-based next-generation sequencing (NGS) and immunohistochemistry (IHC)-based testing. Through expert discussion on the latest evidence, guidelines, and actionable clinical insights, participants will gain tools they can immediately apply in clinical practice.Don’t miss the downloadable point-of-care resource, NSCLC Biomarker Testing Blueprint, to support clinicians in guideline-concordant comprehensive biomarker testing in advanced NSCLC.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedAug 31, 2026
-
Last day to claim creditAug 31, 2027 11 months left
-
PRIME Education, Inc. (PRIME®) Optimizing Biomarker Testing and First-Line Treatment Selection in Metastatic NSCLC
-
PRIME Education, Inc. (PRIME®) From Guidelines to Practice: Enhancing Biomarker Testing and Treatment Selection in NSCLC
-
PRIME Education, Inc. (PRIME®) Evidence-Based Approaches to Biomarker Testing and Targeted Therapy in NSCLC
